BioStock’s article series on autoimmune disease: Drug development for RA and MS

Therapies for autoimmune diseases are available but do not work for all patients, and when they do, side effects can be severe. There is a strong need for new therapies and therefore there is a large market potential, especially for treatments targeting rheumatoid arthritis and multiple sclerosis. In this third segment of the article series, BioStock [...]

2019-09-02T19:17:49+00:00